Impact of CagriSema’s Phase 3 Data Readout on Novo Nordisk BMO Capital Lowers Price Target on Novo Nordisk BMO Capital recently announced that it has lowered the price target on Novo Nordisk (NVO) from $156 to $105. Despite this decrease, the firm maintains an Outperform rating on the shares. The reason for this decision stems…
Breaking News: FDA Approves Expanded Indication for IMCIVREE® to Include Children as Young as 2 Years Old Redefining Treatment for Rare Neuroendocrine Diseases By: Medical Correspondent In a groundbreaking development, Rhythm Pharmaceuticals, Inc. has received approval from the U.S. Food and Drug Administration (FDA) to expand the indication for IMCIVREE® (setmelanotide) to include children as…
Exciting News from Carnival Corporation & plc Today was a momentous day for Carnival Corporation & plc as they held their Fourth Quarter 2024 Earnings Conference Call. The conference call, which took place on December 20, 2024 at 10:00 AM ET, featured key company executives including Beth Roberts, SVP of Investor Relations, CEO Josh Weinstein,…
The Impact of Shareholder Rights Litigation on Investors Overview LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Flux Power Holdings, Inc. (“Flux Power” or “the Company”) (NASDAQ:FLUX) for violations of 10(b) and 20(a) of the…
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Zeta Global Holdings Corp. LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zeta Global Holdings Corp. (“Zeta” or “the Company”) (NYSE:ZETA) for violations of 10(b)…
Charmingly Eccentric: The Year of U.S. Equity Markets in 2024 A Closer Look at Global Equity Markets U.S. equity markets saw a fantastic year in 2024, with impressive returns that left investors feeling optimistic about the future. However, the same could not be said for many developed equity markets around the world. In fact, in…
Rosen Law Firm Reminds PACS Group Inc. Investors of Lead Plaintiff Deadline New York, Dec. 20, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection…
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Visa Inc. Investors Beware: Lawsuit Against Visa Inc. The Schall Law Firm, a national shareholder rights litigation firm, has issued a reminder to investors regarding a class action lawsuit against Visa Inc. (“Visa” or “the Company”). The lawsuit alleges violations of 10(b) and 20(a)…
